diabetic nephropathy

Open Access
Integrating Patient Priorities with Science by Community Engagement in the Kidney Precision Medicine Project
Katherine R. Tuttle, Richard Knight, Paul S. Appelbaum, Tanima Arora, Shweta Bansal, Jack Bebiak, Keith Brown, Catherine Campbell, Leslie Cooperman, Celia P. Corona-Villalobos, Ashveena Dighe, Ian H. de Boer, Daniel E. Hall, Nichole Jefferson, Stacey Jolly, Asra Kermani, Simon C. Lee, Karla Mehl, Raghavan Murugan, Glenda V. Roberts, Sylvia E. Rosas, Jonathan Himmelfarb, R. Tyler Miller and for the Kidney Precision Medicine Project

CJASN April 2021, 16 (4) 660-668; DOI: https://doi.org/10.2215/CJN.10270620

Add to Selected Citations
You have accessRestricted Access
Network Meta-Analysis of Novel Glucose-Lowering Drugs on Risk of Acute Kidney Injury
Min Zhao, Shusen Sun, Zhenguang Huang, Tiansheng Wang and Huilin Tang

CJASN January 2021, 16 (1) 70-78; DOI: https://doi.org/10.2215/CJN.11220720

Add to Selected Citations
You have accessRestricted Access
Effects of Canagliflozin in Patients with Baseline eGFR <30 ml/min per 1.73 m²
George Bakris, Megumi Oshima, Kenneth W. Mahaffey, Rajiv Agarwal, Christopher P. Cannon, George Capuano, David M. Charytan, Dick de Zeeuw, Robert Edwards, Tom Greene, Hiddo J.L. Heerspink, Adeera Levin, Bruce Neal, Richard Oh, Carol Pollock, Norman Rosenthal, David C. Wheeler, Hong Zhang, Bernard Zinman, Meg J. Jardine and Vlado Perkovic

CJASN December 2020, 15 (12) 1705-1714; DOI: https://doi.org/10.2215/CJN.10140620

Add to Selected Citations
Open Access
Empagliflozin and Cardiovascular and Kidney Outcomes across KDIGO Risk Categories
Adeera Levin, Vlado Perkovic, David C. Wheeler, Stefan Hantel, Jyothis T. George, Maximilian von Eynatten, Audrey Koitka-Weber, Christoph Wanner and on behalf of the EMPA-REG OUTCOME Investigators

CJASN October 2020, 15 (10) 1433-1444; DOI: https://doi.org/10.2215/CJN.14901219

Add to Selected Citations
Open Access
The Use of Genomics to Drive Kidney Disease Drug Discovery and Development
Dermot F. Reilly and Matthew D. Breyer

CJASN September 2020, 15 (9) 1342-1351; DOI: https://doi.org/10.2215/CJN.11070919

Add to Selected Citations
You have accessRestricted Access
The Feasibility and Safety of Obtaining Research Kidney Biopsy Cores in Patients with Diabetes
Jonathan J. Hogan, Jonathan G. Owen, Shira J. Blady, Salem Almaani, Rupali S. Avasare, Shweta Bansal, Oliver Lenz, Randy L. Luciano, Samir V. Parikh, Michael J. Ross, Deep Sharma, Harold Szerlip, Shikha Wadhwani, Raymond R. Townsend, Matthew B. Palmer, Katalin Susztak, Amy K. Mottl and for the TRIDENT Study Investigators

CJASN July 2020, 15 (7) 1024-1026; DOI: https://doi.org/10.2215/CJN.13061019

Add to Selected Citations
Open Access
SONAR
Michael Walsh

CJASN June 2020, 15 (6) 889-891; DOI: https://doi.org/10.2215/CJN.08540719

Add to Selected Citations
You have accessRestricted Access
Metabolic Disorders with Kidney Transplant
Elizabeth Cohen, Maria Korah, Glenda Callender, Renata Belfort de Aguiar and Danielle Haakinson

CJASN May 2020, 15 (5) 732-742; DOI: https://doi.org/10.2215/CJN.09310819

Add to Selected Citations
You have accessRestricted Access
Liraglutide for the Treatment of Type 2 Diabetes and Safety in Diabetic Kidney Disease
David Z. Cherney and Katherine R. Tuttle

CJASN April 2020, 15 (4) 444-446; DOI: https://doi.org/10.2215/CJN.01260120

Add to Selected Citations
You have accessRestricted Access
Carbamylated Lipoproteins and Progression of Diabetic Kidney Disease
Kathryn C.B. Tan, Ching-Lung Cheung, Alan C.H. Lee, Joanne K.Y. Lam, Ying Wong and Sammy W.M. Shiu

CJASN March 2020, 15 (3) 359-366; DOI: https://doi.org/10.2215/CJN.11710919

Add to Selected Citations

Main menu

User menu

Search

diabetic nephropathy

Pages

Articles

Information for Authors

About

Journal Information

More Information